Holen Sie sich die Stockscreener-App
17.03
3.65%
0.60
Handel nachbörslich:
17.03
Schlusskurs vom Vortag:
$16.43
Offen:
$16.51
24-Stunden-Volumen:
1.06M
Relative Volume:
1.08
Marktkapitalisierung:
$758.89M
Einnahmen:
$110.24M
Nettoeinkommen (Verlust:
$-66.44M
KGV:
-11.27
EPS:
-1.5111
Netto-Cashflow:
$-61.12M
1W Leistung:
+1.61%
1M Leistung:
+24.13%
6M Leistung:
-15.44%
1J Leistung:
+25.59%
1-Tages-Spanne:
$15.92
$17.09
1-Wochen-Bereich:
$15.68
$17.57
52-Wochen-Spanne:
$8.80
$32.71
Beta Bionics Inc Stock (BBNX) Company Profile
Firmenname
Beta Bionics Inc
Sektor
Branche
Telefon
949-427-7785
Adresse
11 HUGHES, IRVINE
Compare BBNX vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
17.03 | 758.89M | 110.24M | -66.44M | -61.12M | -1.5111 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-09 | Eingeleitet | UBS | Buy |
| 2026-01-27 | Eingeleitet | TD Cowen | Hold |
| 2026-01-09 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-10-21 | Fortgesetzt | Stifel | Buy |
| 2025-10-01 | Hochstufung | Goldman | Neutral → Buy |
| 2025-06-16 | Eingeleitet | Truist | Buy |
| 2025-06-12 | Eingeleitet | Lake Street | Buy |
| 2025-05-30 | Eingeleitet | Goldman | Neutral |
| 2025-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2025-02-24 | Eingeleitet | BofA Securities | Buy |
| 2025-02-24 | Eingeleitet | Lake Street | Buy |
| 2025-02-24 | Eingeleitet | Leerink Partners | Outperform |
| 2025-02-24 | Eingeleitet | Piper Sandler | Overweight |
| 2025-02-24 | Eingeleitet | Stifel | Buy |
| 2025-02-20 | Eingeleitet | Ladenburg Thalmann | Neutral |
| 2025-02-20 | Eingeleitet | Robert W. Baird | Neutral |
Alle ansehen
Beta Bionics Inc Aktie (BBNX) Neueste Nachrichten
BBNX Shareholder Alert: Robbins LLP Reminds Beta Bionics, Inc. Stockholders that it is Investigating the Company's Officers and Directors to Determine if They Violated Securities Laws and Breached Fiduciary Duties to Shareholders - AOL.com
ETFs Investing in Beta Bionics, Inc. Stocks - TradingView
Price to earnings forward of Beta Bionics, Inc. – NASDAQ:BBNX - TradingView
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
BBNX PE Ratio & Valuation, Is BBNX Overvalued - Intellectia AI
Beta Bionics CFO Stephen Feider sells $170k of BBNX stock By Investing.com - Investing.com South Africa
Beta Bionics CFO Stephen Feider sells $170k of BBNX stock - Investing.com
Form 4 Beta Bionics Inc For: 2 July By Investing.com - Investing.com Canada
CFO trades 10,000 Beta Bionics (BBNX) shares under Rule 10b5-1 plan - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Is Investigating Beta Bionics, Inc. (BBNX) And Encourages Investors to Connect - The National Law Review
Beta Bionics to announce Q2 2026 financial results on July 29 - scanx.trade
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Beta Bionics Investor Alert: Johnson Fistel Reviews Potential Claims for Shareholders - PR Newswire
Beta Bionics to Announce Second Quarter 2026 Financial Results on July 29, 2026 - The Manila Times
Beta Bionics sets July 29 call for Q2 2026 results - Stock Titan
Beta Bionics (BBNX) CFO sells 10,000 shares under 10b5-1 trading plan - Stock Titan
Beta Bionics: Some Stabilization In Sight (NASDAQ:BBNX) - Seeking Alpha
BBNX Q1 2026 Earnings: EPS Slightly Beats Estimates Amid Pre-Revenue Stage, Stock Declines 7.8%Earnings Expansion Phase - dars.gov.et
Form 144 Beta Bionics For: 29 June By Investing.com - Investing.com Nigeria
BBNX (NASDAQ: BBNX) notice: proposed sale of 4,896 shares on 06/29/2026 - Stock Titan
Beta Bionics, Inc.(NasdaqGM: BBNX) dropped from Russell 2000 Growth Benchmark - marketscreener.com
Beta Bionics, Inc.(NasdaqGM: BBNX) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Beta Bionics, Inc.(NasdaqGM:BBNX) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
Beta Bionics, Inc.(NasdaqGM: BBNX) dropped from Russell 3000 Growth Benchmark - marketscreener.com
Form 144 Beta Bionics For: 26 June By Investing.com - Investing.com Australia
Form 4 Beta Bionics Inc For: 25 June By Investing.com - Investing.com Australia
BBNX (NASDAQ) insider notice: 5,104 option shares proposed for resale 06/26/2026 - Stock Titan
Beta Bionics, Inc. Actuals & Estimates (BOATS:BBNX) - TradingView
Insider Sell: Mark Hopman Sells Shares of Beta Bionics Inc (BBNX) - GuruFocus
Beta bionics CCO Mark Hopman sells $18,880 in stock By Investing.com - Investing.com Australia
Beta bionics CCO Mark Hopman sells $18,880 in stock - Investing.com
Beta Bionics director Christy Jones sells $21,090 in stock - Investing.com
Beta Bionics director Christy Jones sells $21,090 in stock By Investing.com - Investing.com Australia
Beta Bionics (BBNX) CCO logs 1,258-share Rule 10b5-1 stock sale - Stock Titan
Director Christy Jones sells BBNX shares under Rule 10b5-1 plan - Stock Titan
BBNX Forecast — Price Target — Prediction for 2027 - TradingView
Midday Stock Roundup: Glaukos Rises 4% After Phase 2 Enrollment Completed - Orange County Business Journal
Form 144 Beta Bionics For: 24 June By Investing.com - Investing.com India
Form 144 BETA BIONICS For: 24 June By Investing.com - Investing.com South Africa
Finanzdaten der Beta Bionics Inc-Aktie (BBNX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):